latest news releases from the newsroom
TASER International, Inc.
TASER International, Inc. Reports 23 Percent Revenue Growth in Second Quarter 2006
SCOTTSDALE, Ariz., July 26, 2006 (PRIMEZONE) -- TASER International, Inc. (Nasdaq:TASR) a market leader in advanced electronic control devices reported today that revenues for the second quarter of 2006 were $16.2 million, a 23% increase over the same quarter of the prior year. Operating income for the quarter was $2.2 million, or a 224% increase compared with $686,000 in the prior year period. Net income and basic and diluted earnings per share for the second quarter were $1.5 million which rounds down to $0.02 per share. Business also continued to improve sequentially as revenues in the second quarter of 2006 increased by $2.3 million over the first quarter of 2006 and operating income improved from 7.5% to 13.7% of revenue as the Company continues to improve its operating leverage. The Company generated $4.1 million of cash from operations in the second quarter of 2006 which increased the total cash, cash equivalents and investments balance to $49.1 million.
OTC Stock Review Issues Report on Goldrea Resources Corp.
ATLANTA, July 26, 2006 (PRIMEZONE) -- OTC Stock Review announces that it has initiated coverage of Goldrea Resources Corp. (Pink Sheets:GORAF) (TSX-V:GOR). Goldrea Resources Corp., headquartered in White Rock, BC, is a mineral exploration and development company that is engaged in the acquisition, exploration, and development of mineral properties. The Company has been working on several gold projects in North America and, just over twelve months ago, launched an ambitious play into the Shandong Daye Mine, near Rushan City, Shandong Province, China, the world's fourth largest producer of gold in 2003 (only behind South Africa, Australia and the USA). Shandong Province alone accounts for 26% of the overall Chinese total.
Imaging3's Dominion Poised to Dramatically Improve Speed and Precision of Orthopedic Surgery
BURBANK, Calif., July 26, 2006 (PRIMEZONE) -- Imaging3(tm), Inc. (OTCBB:IMGG) today provided insight into one of the many health care sectors where the company's breakthrough, multi-modality, mobile and real-time 3D imaging technology will have a powerful impact -- orthopedic surgery. The Dominion(tm) will aid patient and doctor alike in this $8.8 billion annual U.S. market that is expected to grow to nearly $14 billion by 2010, according to Datamonitor, New York, NY.
ATMI Reports Strong Second Quarter Financial Results
DANBURY, Conn., July 26, 2006 (PRIMEZONE) -- ATMI, Inc. (Nasdaq:ATMI), a supplier of specialty materials and high-purity materials handling and delivery solutions to the world's leading semiconductor manufacturers, today announced revenues of $82.5 million for the second quarter of 2006, an increase of 19% from $69.3 million in the second quarter of 2005. Net income for the quarter increased by 26% to $10.1 million from $8.0 million in the second quarter of 2005, and earnings per share increased to $0.27 per diluted share from $0.22 per diluted share in the second quarter of 2005. Earnings per share includes share-based compensation expense of $0.05 per diluted share in the second quarter of 2006, compared to $0.01 per diluted share in the second quarter of 2005, inclusive of the adoption of FAS 123(R) in 2006.
SmallCap Sentinel: Content, Content, Content is the New Location, Location, Location
IRVINE, Calif., July 26, 2006 (PRIMEZONE) -- "Content may well supplant 'location' in the axiomatic business mantra of 'location, location, location,'" said SmallCap Sentinel analyst D.R. Clark. "Savvy companies are building broad intellectual property libraries, preferably in digital format, to be eagerly digested by the iPod-toting, media-insatiable consumers of the MySpace Generation."
Metso to Supply Grinding and Flotation Equipment to Gaisky Copper Mine in Russia
HELSINKI, Finland, July 26, 2006 (PRIMEZONE) -- Metso Minerals will supply grinding and flotation equipment to Gaisky copper mine for Ural Mining and Metallurgical Company's raw material complex. The delivery will be completed by the end of 2007. The value of the order is over EUR 20 million. About EUR 17 million was included in the second-quarter order intake, while the rest will be included in the third quarter orders.
Investors of Par Pharmaceutical Companies, Inc. Are Reminded of Securities Class Action Filed Against the Company -- PRX
NEW YORK, July 25, 2006 (PRIMEZONE) -- Pomerantz Haudek Block Grossman & Gross LLP (www.pomerantzlaw.com) ("Pomerantz") reminds investors of Par Pharmaceutical Companies, Inc. ("Par" or the "Company") (NYSE:PRX) that a class action lawsuit has been filed by in the United States District Court for the District of New Jersey, against the Company and certain of its officers. The class action was filed on behalf of purchasers of the common stock of the Company during the period from April 29, 2004 to July 5, 2006, inclusive (the "Class Period"). The complaint alleges violations of Sections 10(b) and 20(a) the Securities Exchange Act of 1934 and Rule10b-5 promulgated thereunder.